SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-005904
Filing Date
2021-05-05
Accepted
2021-05-05 16:02:50
Documents
72
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kala-20210331x10q.htm   iXBRL 10-Q 1708123
2 EX-31.1 kala-20210331xex31d1.htm EX-31.1 15220
3 EX-31.2 kala-20210331xex31d2.htm EX-31.2 15180
4 EX-32.1 kala-20210331xex32d1.htm EX-32.1 6715
5 EX-32.2 kala-20210331xex32d2.htm EX-32.2 6814
  Complete submission text file 0001558370-21-005904.txt   6370752

Data Files

Seq Description Document Type Size
6 EX-101.SCH kala-20210331.xsd EX-101.SCH 50778
7 EX-101.CAL kala-20210331_cal.xml EX-101.CAL 49961
8 EX-101.DEF kala-20210331_def.xml EX-101.DEF 147556
9 EX-101.LAB kala-20210331_lab.xml EX-101.LAB 436433
10 EX-101.PRE kala-20210331_pre.xml EX-101.PRE 299521
11 EXTRACTED XBRL INSTANCE DOCUMENT kala-20210331x10q_htm.xml XML 1017441
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38150 | Film No.: 21893128
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences